These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31231966)

  • 1. Selective Cell Penetrating Peptide-Functionalized Envelope-Type Chimeric Lipopepsomes Boost Systemic RNAi Therapy for Lung Tumors.
    Qiu M; Ouyang J; Wei Y; Zhang J; Lan Q; Deng C; Zhong Z
    Adv Healthc Mater; 2019 Aug; 8(16):e1900500. PubMed ID: 31231966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-Mimicking Chimaeric Polymersomes Boost Targeted Cancer siRNA Therapy In Vivo.
    Zou Y; Zheng M; Yang W; Meng F; Miyata K; Kim HJ; Kataoka K; Zhong Z
    Adv Mater; 2017 Nov; 29(42):. PubMed ID: 28961339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced lysosomal escape of cell penetrating peptide-functionalized metal-organic frameworks for co-delivery of survivin siRNA and oridonin.
    Cai M; Yao Y; Yin D; Zhu R; Fu T; Kong J; Wang K; Liu J; Yao A; Ruan Y; Shi W; Zhu Q; Ni J; Yin X
    J Colloid Interface Sci; 2023 Sep; 646():370-380. PubMed ID: 37207419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopepsomes: A novel and robust family of nano-vesicles capable of highly efficient encapsulation and tumor-targeted delivery of doxorubicin hydrochloride in vivo.
    Qiu M; Sun H; Meng F; Cheng R; Zhang J; Deng C; Zhong Z
    J Control Release; 2018 Feb; 272():107-113. PubMed ID: 29355618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Cell Penetrating Peptide-Functionalized Polymersomes Mediate Efficient and Targeted Delivery of Methotrexate Disodium to Human Lung Cancer In Vivo.
    Yang W; Xia Y; Fang Y; Meng F; Zhang J; Cheng R; Deng C; Zhong Z
    Adv Healthc Mater; 2018 Apr; 7(7):e1701135. PubMed ID: 29280317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumor lineage-homing cell-penetrating peptide.
    Lin C; Zhang X; Chen H; Bian Z; Zhang G; Riaz MK; Tyagi D; Lin G; Zhang Y; Wang J; Lu A; Yang Z
    Drug Deliv; 2018 Nov; 25(1):256-266. PubMed ID: 29334814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boosting RNAi therapy for orthotopic glioblastoma with nontoxic brain-targeting chimaeric polymersomes.
    Shi Y; Jiang Y; Cao J; Yang W; Zhang J; Meng F; Zhong Z
    J Control Release; 2018 Dec; 292():163-171. PubMed ID: 30408555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody h-R3-dendrimer mediated siRNA has excellent endosomal escape and tumor targeted delivery ability, and represents efficient siPLK1 silencing and inhibition of cell proliferation, migration and invasion.
    Li J; Liu J; Li S; Hao Y; Chen L; Zhang X
    Oncotarget; 2016 Mar; 7(12):13782-96. PubMed ID: 26883109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Glutamine-Rich Carrier Efficiently Delivers Anti-CD47 siRNA Driven by a "Glutamine Trap" To Inhibit Lung Cancer Cell Growth.
    Wu J; Li Z; Yang Z; Guo L; Zhang Y; Deng H; Wang C; Feng M
    Mol Pharm; 2018 Aug; 15(8):3032-3045. PubMed ID: 29939755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer.
    McCarroll JA; Dwarte T; Baigude H; Dang J; Yang L; Erlich RB; Kimpton K; Teo J; Sagnella SM; Akerfeldt MC; Liu J; Phillips PA; Rana TM; Kavallaris M
    Oncotarget; 2015 May; 6(14):12020-34. PubMed ID: 25557168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugates of HA2 with octaarginine-grafted HPMA copolymer offer effective siRNA delivery and gene silencing in cancer cells.
    Golan M; Feinshtein V; David A
    Eur J Pharm Biopharm; 2016 Dec; 109():103-112. PubMed ID: 27702685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of elastin-like polypeptide for targeted specific gene delivery in vivo.
    Yi A; Sim D; Lee YJ; Sarangthem V; Park RW
    J Nanobiotechnology; 2020 Jan; 18(1):15. PubMed ID: 31952530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endosomolytic and Tumor-Penetrating Mesoporous Silica Nanoparticles for siRNA/miRNA Combination Cancer Therapy.
    Wang Y; Xie Y; Kilchrist KV; Li J; Duvall CL; Oupický D
    ACS Appl Mater Interfaces; 2020 Jan; 12(4):4308-4322. PubMed ID: 31939276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granzyme B-loaded, cell-selective penetrating and reduction-responsive polymersomes effectively inhibit progression of orthotopic human lung tumor in vivo.
    Yang W; Wei Y; Yang L; Zhang J; Zhong Z; Storm G; Meng F
    J Control Release; 2018 Nov; 290():141-149. PubMed ID: 30312720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of the human TERT gene by RNAi inhibits A549 lung adenocarcinoma cell growth in vitro and in vivo.
    Xie M; Chen Q; He S; Li B; Hu C
    Oncol Rep; 2011 Oct; 26(4):1019-27. PubMed ID: 21743972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ROS-Responsive Polymeric siRNA Nanomedicine Stabilized by Triple Interactions for the Robust Glioblastoma Combinational RNAi Therapy.
    Zheng M; Liu Y; Wang Y; Zhang D; Zou Y; Ruan W; Yin J; Tao W; Park JB; Shi B
    Adv Mater; 2019 Sep; 31(37):e1903277. PubMed ID: 31348581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of tumor growth in lung cancer xenograft model mice by poly(sorbitol-co-PEI)-mediated delivery of osteopontin siRNA.
    Cho WY; Hong SH; Singh B; Islam MA; Lee S; Lee AY; Gankhuyag N; Kim JE; Yu KN; Kim KH; Park YC; Cho CS; Cho MH
    Eur J Pharm Biopharm; 2015 Aug; 94():450-62. PubMed ID: 26141346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic delivery of siRNA by aminated poly(α)glutamate for the treatment of solid tumors.
    Polyak D; Krivitsky A; Scomparin A; Eliyahu S; Kalinski H; Avkin-Nachum S; Satchi-Fainaro R
    J Control Release; 2017 Jul; 257():132-143. PubMed ID: 27356019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of Cationic Multiwalled Carbon Nanotubes as Efficient siRNA Vectors for Lung Cancer Xenograft Eradication.
    Guo C; Al-Jamal WT; Toma FM; Bianco A; Prato M; Al-Jamal KT; Kostarelos K
    Bioconjug Chem; 2015 Jul; 26(7):1370-9. PubMed ID: 26036843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sialic Acid-Targeted Nanovectors with Phenylboronic Acid-Grafted Polyethylenimine Robustly Enhance siRNA-Based Cancer Therapy.
    Ji M; Li P; Sheng N; Liu L; Pan H; Wang C; Cai L; Ma Y
    ACS Appl Mater Interfaces; 2016 Apr; 8(15):9565-76. PubMed ID: 27007621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.